Literature DB >> 9892697

Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.

A A McCormick1, M H Kumagai, K Hanley, T H Turpen, I Hakim, L K Grill, D Tusé, S Levy, R Levy.   

Abstract

Rapid production of protein-based tumor-specific vaccines for the treatment of malignancies is possible with the plant-based transient expression system described here. We created a modified tobamoviral vector that encodes the idiotype-specific single-chain Fv fragment (scFv) of the immunoglobulin from the 38C13 mouse B cell lymphoma. Infected Nicotiana benthamiana plants contain high levels of secreted scFv protein in the extracellular compartment. This material reacts with an anti-idiotype antibody by Western blotting, ELISA, and affinity chromatography, suggesting that the plant-produced 38C13 scFv protein is properly folded in solution. Mice vaccinated with the affinity-purified 38C13 scFv generate >10 micrograms/ml anti-idiotype immunoglobulins. These mice were protected from challenge by a lethal dose of the syngeneic 38C13 tumor, similar to mice immunized with the native 38C13 IgM-keyhole limpet hemocyanin conjugate vaccine. This rapid production system for generating tumor-specific protein vaccines may provide a viable strategy for the treatment of non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892697      PMCID: PMC15200          DOI: 10.1073/pnas.96.2.703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Expression of functional antibody Fv and Fab fragments in Escherichia coli.

Authors:  A Plückthun; A Skerra
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

2.  Gel-staining techniques.

Authors:  C R Merril
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 3.  Man-made antibodies.

Authors:  G Winter; C Milstein
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

4.  Spontaneous murine B-cell leukaemia.

Authors:  S Slavin; S Strober
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

5.  Enhancement of peptide immunogenicity by linear polymerization.

Authors:  F Borras-Cuesta; Y Fedon; A Petit-Camurdan
Journal:  Eur J Immunol       Date:  1988-02       Impact factor: 5.532

6.  Mouse x human heterohybridomas as fusion partners with human B cell tumors.

Authors:  W L Carroll; K Thielemans; J Dilley; R Levy
Journal:  J Immunol Methods       Date:  1986-05-01       Impact factor: 2.303

7.  cDNA cloning of the complete genome of tobacco mosaic virus and production of infectious transcripts.

Authors:  W O Dawson; D L Beck; D A Knorr; G L Grantham
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  A purified saponin acts as an adjuvant for a T-independent antigen.

Authors:  A C White; P Cloutier; R T Coughlin
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

9.  Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.

Authors:  L W Kwak; M J Campbell; D K Czerwinski; S Hart; R A Miller; R Levy
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

10.  The alpha-amylase genes in Oryza sativa: characterization of cDNA clones and mRNA expression during seed germination.

Authors:  S D O'Neill; M H Kumagai; A Majumdar; N Huang; T D Sutliff; R L Rodriguez
Journal:  Mol Gen Genet       Date:  1990-04
View more
  33 in total

Review 1.  'Molecular farming' of antibodies in plants.

Authors:  Stefan Schillberg; Rainer Fischer; Neil Emans
Journal:  Naturwissenschaften       Date:  2003-02-18

Review 2.  Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.

Authors:  Hyun Jun Park; Sattva S Neelapu
Journal:  Br J Haematol       Date:  2008-04-13       Impact factor: 6.998

Review 3.  Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.

Authors:  Kannan Badri Narayanan; Sung Soo Han
Journal:  Virus Genes       Date:  2018-07-14       Impact factor: 2.332

Review 4.  Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.

Authors:  Flavio E Baio; Larry W Kwak; Jinsheng Weng
Journal:  Am J Blood Res       Date:  2014-12-15

5.  Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65).

Authors:  Linda Avesani; Alberto Falorni; Giovanni Battista Tornielli; Carla Marusic; Andrea Porceddu; Annalisa Polverari; Claudia Faleri; Filippo Calcinaro; Mario Pezzotti
Journal:  Transgenic Res       Date:  2003-04       Impact factor: 2.788

Review 6.  Immunotherapy for lymphomas.

Authors:  John M Timmerman
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

7.  Tumor targeting of humanized fragment antibody secreted from transgenic rice cell suspension culture.

Authors:  Shin-Young Hong; Tae-Sup Lee; Ju Kim; Jae-Ho Jung; Chang-Woon Choi; Tae-Geum Kim; Tae-Ho Kwon; Yong-Suk Jang; Moon-Sik Yang
Journal:  Plant Mol Biol       Date:  2008-08-01       Impact factor: 4.076

8.  The expression of a mountain cedar allergen comparing plant-viral apoplastic and yeast expression systems.

Authors:  Marcie H Moehnke; Terumi Midoro-Horiuti; Randall M Goldblum; Christopher M Kearney
Journal:  Biotechnol Lett       Date:  2008-02-13       Impact factor: 2.461

9.  Expression of anti human IL-4 and IL-6 scFvs in transgenic tobacco plants.

Authors:  P Ehsani; A Meunier; F Nato; A Jafari; A Nato; P Lafaye
Journal:  Plant Mol Biol       Date:  2003-05       Impact factor: 4.076

Review 10.  Progress and challenges in the vaccine-based treatment of head and neck cancers.

Authors:  Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.